“十四五”期间产值年均增长16%
Xin Lang Cai Jing·2026-01-04 22:09

Group 1 - The core industry of the Tianjin Binhai High-tech Zone during the 14th Five-Year Plan period is biomedicine, with an average annual output growth rate of 16% [1] - The high-tech zone has established a matrix of national key laboratories, including the Haihe Laboratory and municipal key laboratories, and has nearly 20 national-level innovation platforms and over 60 municipal innovation platforms in the biomedicine field [1] - Huyuan Biotechnology Co., Ltd. is a leading company in the field of innovative drug research and industrialization for immune cell therapy, with its first product "Yuanruida" filling a gap in the treatment of adult acute lymphoblastic leukemia [1] Group 2 - The high-tech zone provides comprehensive and systematic support for companies, including pre-consultation, coordination during the process, and post-service, which has helped Huyuan Biotechnology obtain the first drug production license in the cell field in the Beijing-Tianjin-Hebei region [2] - The high-tech zone has gathered over 100 companies in the cell and gene therapy industry chain, forming a complete industrial chain that includes cell extraction, storage, cold chain logistics, innovative research and development, and clinical applications [2] - Tianjin Hengyu Medical Technology Co., Ltd. has achieved significant results in intravascular ultrasound and optical coherence tomography since its establishment in the high-tech zone, aiming for a multi-modal imaging goal [2] Group 3 - Looking ahead to the 15th Five-Year Plan, the high-tech zone aims to become a national leader in biotechnology and biomanufacturing, focusing on core industries such as innovative drugs, medical devices, cell therapy, brain-machine interaction, and medical services [3] - The high-tech zone plans to strengthen the "Cell Valley" and "China Brain-Machine Valley" as key innovation and industrial hubs, while also exploring potential industries like biomanufacturing and health care [3] - The goal is to develop the biomedicine industry in the high-tech zone into a nationally influential and globally competitive landmark industrial cluster [3]

“十四五”期间产值年均增长16% - Reportify